Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

NCT01969110 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-10-25

No results posted yet for this study

Summary

The purpose of this study is to investigate whether perioperative immunonutrition has additional effects on cell-mediated immunity in patients undergoing pancreaticoduodenectomy.

Conditions

  • Pancreatic Tumor
  • Bile Duct Tumor

Interventions

DIETARY_SUPPLEMENT

Oral IMPACT

Oral IMPACT enriched with arginine, omega-3 fatty acids, and RNA by enteral feeding after surgery

Sponsors & Collaborators

  • Chiba University

    lead OTHER

Principal Investigators

  • Katsunori Furukawa, MD · Chiba University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01969110 on ClinicalTrials.gov